Perego P - Search Results

1

The rediscovery of platinum-based cancer therapy.

Rottenberg S, Disler C, Perego P. Rottenberg S, et al. Among authors: perego p. Nat Rev Cancer. 2021 Jan;21(1):37-50. doi: 10.1038/s41568-020-00308-y. Epub 2020 Oct 30. Nat Rev Cancer. 2021. PMID: 33128031 Review.

2

Extra-cellular thiol metabolism in clones of human metastatic melanoma with different gamma-glutamyl transpeptidase expression: implications for cell response to platinum-based drugs.

Paolicchi A, Lorenzini E, Perego P, Supino R, Zunino F, Comporti M, Pompella A. Paolicchi A, et al. Among authors: perego p. Int J Cancer. 2002 Feb 20;97(6):740-5. doi: 10.1002/ijc.10110. Int J Cancer. 2002. PMID: 11857348

3

Development of resistance to a trinuclear platinum complex in ovarian carcinoma cells.

Perego P, Gatti L, Righetti SC, Beretta GL, Carenini N, Corna E, Dal Bo L, Tinelli S, Colangelo D, Leone R, Apostoli P, Lombardi L, Beggiolin G, Piazzoni L, Zunino F. Perego P, et al. Int J Cancer. 2003 Jul 10;105(5):617-24. doi: 10.1002/ijc.11140. Int J Cancer. 2003. PMID: 12740909

4

Molecular alterations of cells resistant to platinum drugs: role of PKCalpha.

Righetti SC, Perego P, Carenini N, Corna E, Dal Bo L, Cedrola S, La Porta CA, Zunino F. Righetti SC, et al. Among authors: perego p. Biochim Biophys Acta. 2006 Jan;1763(1):93-100. doi: 10.1016/j.bbamcr.2005.12.007. Epub 2006 Jan 6. Biochim Biophys Acta. 2006. PMID: 16473140 Free article.

5

Modulation of survival pathways in ovarian carcinoma cell lines resistant to platinum compounds.

Benedetti V, Perego P, Luca Beretta G, Corna E, Tinelli S, Righetti SC, Leone R, Apostoli P, Lanzi C, Zunino F. Benedetti V, et al. Among authors: perego p. Mol Cancer Ther. 2008 Mar;7(3):679-87. doi: 10.1158/1535-7163.MCT-07-0450. Mol Cancer Ther. 2008. PMID: 18347153 Free article.

6

Strategies to improve the efficacy of platinum compounds.

Cossa G, Gatti L, Zunino F, Perego P. Cossa G, et al. Among authors: perego p. Curr Med Chem. 2009;16(19):2355-65. doi: 10.2174/092986709788682083. Curr Med Chem. 2009. PMID: 19601785 Review.

7

Novel bis-platinum complexes endowed with an improved pharmacological profile.

Gatti L, Perego P, Leone R, Apostoli P, Carenini N, Corna E, Allievi C, Bastrup U, De Munari S, Di Giovine S, Nicoli P, Grugni M, Natangelo M, Pardi G, Pezzoni G, Singer JW, Zunino F. Gatti L, et al. Among authors: perego p. Mol Pharm. 2010 Feb 1;7(1):207-16. doi: 10.1021/mp900211j. Mol Pharm. 2010. PMID: 19919086

8

Drug combinations with proteasome inhibitors in antitumor therapy.

Gatti L, Zuco V, Zaffaroni N, Perego P. Gatti L, et al. Among authors: perego p. Curr Pharm Des. 2013;19(22):4094-114. doi: 10.2174/1381612811319220015. Curr Pharm Des. 2013. PMID: 23181571 Review.

9

The ubiquitin proteasome system as a source of drug targets for cancer therapy.

Perego P. Perego P. Curr Pharm Des. 2013;19(22):4024. doi: 10.2174/1381612811319220011. Curr Pharm Des. 2013. PMID: 23181577 No abstract available.

10

Differential outcome of MEK1/2 inhibitor-platinum combinations in platinum-sensitive and -resistant ovarian carcinoma cells.

Cossa G, Lanzi C, Cassinelli G, Carenini N, Arrighetti N, Gatti L, Corna E, Zunino F, Zaffaroni N, Perego P. Cossa G, et al. Among authors: perego p. Cancer Lett. 2014 Jun 1;347(2):212-24. doi: 10.1016/j.canlet.2014.02.016. Epub 2014 Feb 24. Cancer Lett. 2014. PMID: 24576622

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

341 results

Search Page

Filters